Enzyme replacement
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB15874 | Agalsidase alfa | A recombinant human alpha-galactosidase indicated to treat Fabry disease, a genetic deficiency in the enzyme leading to buildup of globotriaosylceramide. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB15874 | Agalsidase alfa | Cation-dependent mannose-6-phosphate receptor | transporter |
| DB15874 | Agalsidase alfa | Globotriaosylceramide | target |
| Drug | Drug Name | Phase | Status | Count |
|---|